30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Holding Companies

POINT Biopharma Global Inc (PNT)

Track

Stock chart
Ticker: PNT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BVF PARTNERS L P/IL
3 sales — total 213,657,911 USD
Sale 18 Dec 2023
Value US$1,843,999.75 | Price 105.32 | Shares 34,724
Sale 18 Dec 2023
Value US$2,056,043.76 | Price 460.24 | Shares 2,187
Sale 18 Dec 2023
Value US$111,729,350.25 | Price 12.45 | Shares 8,974,245
Buy 29 Nov 2022
Value US$3,122,990.70 | Price 99.45 | Shares 35,394
Buy 28 Nov 2022
Value US$24,642.00 | Price 6.66 | Shares 3,700
Buy 25 Nov 2022
Value US$24,942.90 | Price 6.82 | Shares 3,660
Buy 23 Nov 2022
Value US$24,660.00 | Price 6.85 | Shares 3,600
Buy 21 Nov 2022
Value US$11,217.60 | Price 6.56 | Shares 1,710
Buy 18 Nov 2022
Value US$145,580.50 | Price 6.50 | Shares 22,397
Buy 18 Nov 2022
Value US$37,980.00 | Price 6.33 | Shares 6,000
Buy 17 Nov 2022
Value US$165,618.00 | Price 6.00 | Shares 27,603
Sale 25 May 2022
Value US$4,237,172.04 | Price 7.51 | Shares 564,204
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-20 2023-12-18 S Sale
4.0
BVF PARTNERS L P/IL
34,724 +6.7%
105.32
US$1,844,000 		34,724 +6.7% 105.32 US$1,844,000
2023-12-20 2023-12-18 S Sale
4.0
BVF PARTNERS L P/IL
2,187 +49.6%
460.24
US$2,056,044 		2,187 +49.6% 460.24 US$2,056,044
2023-12-20 2023-12-18 S Sale
4.0
BVF PARTNERS L P/IL
62,857 +1.9%
188.40
US$2,971,688 		62,857 +1.9% 188.40 US$2,971,688
2022-11-30 2022-11-29 B Purchase
3.0
MCCANN JOE A.

Chief Executive Officer

Executive Director
2,160 +0.1%
6.64
US$14,342 		2,160 +0.1% 6.64 US$14,342
2022-11-28 2022-11-28 B Purchase
2.9
Malik Rajesh
Non-Executive Director
3,700 +inf%
6.66
US$24,642 		3,700 +inf% 6.66 US$24,642
2022-11-28 2022-11-25 B Purchase
2.2
HOGUE GERALD L.
Non-Executive Director
3,660 +inf%
6.82
US$24,943 		3,660 +inf% 6.82 US$24,943
2022-11-28 2022-11-23 B Purchase
2.2
Lubner David Charles
Non-Executive Director
3,600 +inf%
6.85
US$24,660 		3,600 +inf% 6.85 US$24,660
2022-11-23 2022-11-21 B Purchase
2.9
MARGOLIN YAEL
Non-Executive Director
1,710 +inf%
6.56
US$11,218 		1,710 +inf% 6.56 US$11,218
2022-11-21 2022-11-18 B Purchase
3.2
SILBER ALLAN C

Executive Chairman

Executive Director Large shareholder
22,397 +0.5%
6.50
US$145,580 		22,397 +0.5% 6.50 US$145,580
2022-11-21 2022-11-18 B Purchase
3.0
GOODMAN JONATHAN R.
Non-Executive Director
6,000 +16.7%
6.33
US$37,980 		6,000 +16.7% 6.33 US$37,980
2022-11-21 2022-11-17 B Purchase
3.2
SILBER ALLAN C

Executive Chairman

Executive Director Large shareholder
27,603 +0.7%
6.00
US$165,618 		27,603 +0.7% 6.00 US$165,618
2022-05-26 2022-05-25 S Sale
1.4
FLESHNER NEIL E.

Chief Medical Officer

Executive Director
564,204 -15.7%
7.51
US$4,237,172 		564,204 -15.7% 7.51 US$4,237,172
Explore more

More insider trading research around POINT Biopharma Global Inc

More insider trades in United States
Similar Financials companies with insider activity
More Holding Companies companies with insider activity
More Holding Companies companies with insider activity
Insider trading in North America